Updated:
AKCEA THERAPEUTICS, INC.
AKCEA THERAPEUTICS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001662524, and its reported...
Overview
AKCEA THERAPEUTICS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001662524, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2020-03-02, it reported annual revenue of USD 488,543,000; net income of USD 40,772,000; total assets of USD 599,250,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- AKCEA THERAPEUTICS, INC.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Boston, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001662524
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2019USD | $488.5M | $40.8M | $599.3M | $306.9M | $223.8M | |
| FY2018USD | $64.9M | -$225.8M | $365.3M | $86.5M | -$202.9M | |
| FY2017USD | $55.2M | -$109.8M | $268.8M | $58.4M | -$36.2M |
FY2017. Net income: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research AKCEA THERAPEUTICS, INC. in Altss
Track this company’s investors, transactions and relationships in Altss.